| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21.
|
Nat Genet
|
2007
|
8.50
|
|
2
|
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis.
|
J Crohns Colitis
|
2010
|
3.97
|
|
3
|
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management.
|
J Crohns Colitis
|
2012
|
3.69
|
|
4
|
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations.
|
J Crohns Colitis
|
2009
|
3.66
|
|
5
|
Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases.
|
Inflamm Bowel Dis
|
2007
|
2.89
|
|
6
|
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?
|
Am J Gastroenterol
|
2010
|
2.74
|
|
7
|
Once-daily budesonide MMX® extended-release tablets induce remission in patients with mild to moderate ulcerative colitis: results from the CORE I study.
|
Gastroenterology
|
2012
|
2.64
|
|
8
|
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis.
|
J Crohns Colitis
|
2012
|
2.55
|
|
9
|
Development of the Crohn's disease digestive damage score, the Lémann score.
|
Inflamm Bowel Dis
|
2010
|
2.20
|
|
10
|
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations.
|
J Crohns Colitis
|
2012
|
1.71
|
|
11
|
American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006.
|
Gastroenterology
|
2007
|
1.60
|
|
12
|
5-aminosalicylic acids and the risk of renal disease: a large British epidemiologic study.
|
Gastroenterology
|
2004
|
1.57
|
|
13
|
Conventional medical management of inflammatory bowel disease.
|
Gastroenterology
|
2011
|
1.53
|
|
14
|
Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitis.
|
Gut
|
2010
|
1.53
|
|
15
|
European evidence-based Consensus on the management of ulcerative colitis: Special situations.
|
J Crohns Colitis
|
2008
|
1.34
|
|
16
|
Ciclosporin use in acute ulcerative colitis: a long-term experience.
|
Eur J Gastroenterol Hepatol
|
2005
|
1.16
|
|
17
|
Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease.
|
Inflamm Bowel Dis
|
2009
|
1.14
|
|
18
|
Incidence and clinical significance of immunogenicity to infliximab in Crohn's disease: a critical systematic review.
|
Inflamm Bowel Dis
|
2009
|
1.07
|
|
19
|
Red cell transfusion for the management of upper gastrointestinal haemorrhage.
|
Cochrane Database Syst Rev
|
2010
|
1.05
|
|
20
|
Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion process.
|
Am J Gastroenterol
|
2012
|
0.97
|
|
21
|
METRIC (MREnterography or ulTRasound in Crohn's disease): a study protocol for a multicentre, non-randomised, single-arm, prospective comparison study of magnetic resonance enterography and small bowel ultrasound compared to a reference standard in those aged 16 and over.
|
BMC Gastroenterol
|
2014
|
0.91
|
|
22
|
Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.
|
Am J Gastroenterol
|
2009
|
0.91
|
|
23
|
Collagenous gastritis: reports and systematic review.
|
Eur J Gastroenterol Hepatol
|
2009
|
0.90
|
|
24
|
The European (ECCO) Consensus on infection in IBD: what does it change for the clinician?
|
Gut
|
2009
|
0.87
|
|
25
|
An unusual case of dyspnoea in an elderly man.
|
BMJ Case Rep
|
2010
|
0.81
|
|
26
|
In favour of early surgery in Crohn's disease: a hypothesis to be tested.
|
J Crohns Colitis
|
2010
|
0.81
|
|
27
|
Central Reading of Endoscopy Endpoints in Inflammatory Bowel Disease Trials.
|
Inflamm Bowel Dis
|
2015
|
0.79
|
|
28
|
AST-120 (spherical carbon adsorbent) in the treatment of perianal fistulae in mild-to-moderate Crohn's disease: FHAST-1, a phase 3, multicenter, placebo-controlled study.
|
Inflamm Bowel Dis
|
2014
|
0.79
|
|
29
|
Physician perspectives on unresolved issues in the use of conventional therapy in Crohn's disease: results from an international survey and discussion programme.
|
J Crohns Colitis
|
2011
|
0.78
|
|
30
|
Targeting nanomedicines in the treatment of Crohn's disease: focus on certolizumab pegol (CDP870).
|
Int J Nanomedicine
|
2007
|
0.77
|
|
31
|
IBD care in Europe: A comparative audit of the inpatient management of Crohn's disease and ulcerative colitis using the national UK IBD audit tool.
|
J Crohns Colitis
|
2009
|
0.77
|
|
32
|
Infliximab and azathioprine: bridge or parachute?
|
Gastroenterology
|
2006
|
0.77
|
|
33
|
Red cell transfusion for the management of upper gastrointestinal haemorrhage.
|
Cochrane Database Syst Rev
|
2009
|
0.77
|
|
34
|
On the second ECCO Consensus on Crohn's disease.
|
J Crohns Colitis
|
2010
|
0.77
|
|
35
|
Impact of interobserver disagreement on phenotype-genotype associations in Crohn's disease.
|
Inflamm Bowel Dis
|
2007
|
0.76
|
|
36
|
Reply: budesonide.
|
Gastroenterology
|
2013
|
0.75
|
|
37
|
Colon salvage therapy for acute severe colitis: cyclosporine or infliximab?
|
Curr Opin Gastroenterol
|
2011
|
0.75
|
|
38
|
Leading change in inflammatory bowel disease. Foreword.
|
J Crohns Colitis
|
2012
|
0.75
|
|
39
|
Case of the month #170: the unilateral persistent nephrogram after endovascular aortic aneurysm repair (EVAR): new life in an old sign.
|
Can Assoc Radiol J
|
2011
|
0.75
|
|
40
|
Inflammatory bowel disease, peptic ulcer and diverticular disease as certified causes of death in an English population 1979-2003.
|
Eur J Gastroenterol Hepatol
|
2008
|
0.75
|
|
41
|
Thrombolysis for central venous occlusion causing bilateral chylothorax in a patient with down syndrome.
|
J Vasc Interv Radiol
|
2004
|
0.75
|
|
42
|
Recanalization of an occluded infrainguinal vein graft complicated by graft aneurysm.
|
Cardiovasc Intervent Radiol
|
2007
|
0.75
|
|
43
|
The role of blood transfusion in the management of upper and lower intestinal tract bleeding.
|
Best Pract Res Clin Gastroenterol
|
2008
|
0.75
|
|
44
|
Is IBD associated with a stressful lifestyle?
|
Inflamm Bowel Dis
|
2008
|
0.75
|
|
45
|
Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis.
|
Cochrane Database Syst Rev
|
2017
|
0.75
|